Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,048 mentions
- robotic manipulationmarket834 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology492 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology372 mentions
- vision-language-action modeltechnology355 mentions
- agentic AItechnology353 mentions
- Vision-Language Modeltechnology321 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Microsoftorganization291 mentions
- Googleorganization276 mentions
- NVIDIAorganization264 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology176 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology170 mentions
- IBMorganization163 mentions
Entity
Biocytogen
organization2 mentionslast seen Sep 20, 2026
Global biotechnology company developing antibody therapeutics and Platinum Sponsor of S2S China 2026.
Relationships 6
- Biocytogendevelopsbispecific antibody99% confidence2 sources
- BiocytogendevelopsVHH-based therapeutic99% confidence2 sources
- Biocytogendevelopsmonoclonal antibody99% confidence2 sources
- Biocytogendevelopsantibody-drug conjugate99% confidence2 sources
- Biocytogendepends onRenMice85% confidence1 source
- BiocytogenimplementsRenMice85% confidence1 source
Relationship
BiocytogendevelopsVHH-based therapeutic
99% confidence2 supporting mentions
Either name opens that entity’s relationships.
Sources 2
- newsPR NewswireSep 20, 2026S2S China Announces 2026 Finalists, Ten Standout Teams Set to Pitch Global Investors at Westlake University
broad portfolio of novel drug candidates spanning monoclonal and bispecific antibodies, ADCs, VHH-based therapeutics
- newsPR NewswireSep 20, 2026S2S China Announces 2026 Finalists, Ten Standout Teams Set to Pitch Global Investors at Westlake University
portfolio of novel drug candidates spanning monoclonal and bispecific antibodies, ADCs, VHH-based therapeutics, and other antibody-based modalities